Lastly but most significantly, the small molecule inhibitors currently developed to target androgen biosynthesis or AR signaling, as mentioned in Figure 2B, have limitations in delaying the progression of PCa to the castration-resistance stage. This evidence concerns the gene AR and posterior cortical atrophy.